Novel lipid-lowering agents

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.

Original languageEnglish (US)
Title of host publicationDyslipidemias: Pathophysiology, Evaluation and Management
PublisherHumana Press Inc.
Pages499-519
Number of pages21
ISBN (Print)9781607614241, 9781607614234
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids
Physicians
Safety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ahmad, Z., & Garg, A. (2015). Novel lipid-lowering agents. In Dyslipidemias: Pathophysiology, Evaluation and Management (pp. 499-519). Humana Press Inc.. https://doi.org/10.1007/978-1-60761-424-1_30

Novel lipid-lowering agents. / Ahmad, Zahid; Garg, Abhimanyu.

Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., 2015. p. 499-519.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ahmad, Z & Garg, A 2015, Novel lipid-lowering agents. in Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., pp. 499-519. https://doi.org/10.1007/978-1-60761-424-1_30
Ahmad Z, Garg A. Novel lipid-lowering agents. In Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc. 2015. p. 499-519 https://doi.org/10.1007/978-1-60761-424-1_30
Ahmad, Zahid ; Garg, Abhimanyu. / Novel lipid-lowering agents. Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., 2015. pp. 499-519
@inbook{f0ebe94239104045b0b56731f2c21ec4,
title = "Novel lipid-lowering agents",
abstract = "Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.",
author = "Zahid Ahmad and Abhimanyu Garg",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-60761-424-1_30",
language = "English (US)",
isbn = "9781607614241",
pages = "499--519",
booktitle = "Dyslipidemias: Pathophysiology, Evaluation and Management",
publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Novel lipid-lowering agents

AU - Ahmad, Zahid

AU - Garg, Abhimanyu

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.

AB - Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.

UR - http://www.scopus.com/inward/record.url?scp=84956831051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956831051&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-424-1_30

DO - 10.1007/978-1-60761-424-1_30

M3 - Chapter

AN - SCOPUS:84956831051

SN - 9781607614241

SN - 9781607614234

SP - 499

EP - 519

BT - Dyslipidemias: Pathophysiology, Evaluation and Management

PB - Humana Press Inc.

ER -